|
Market Research Report
Global Drug Eluting Stent Market 2008-2012
|
This publication has been discontinued on May 10, 2011.
Below is the updated product.
Published: May, 2011
Product code: 192214
Abstract
Drug Eluting Stents are used for the treatment of heart patients to prevent
the need for more-invasive procedures, such as coronary artery bypass surgery.
This reduces the need for repeated hospitalization and angioplasty procedures,
thus reducing risks due to complications such as heart attack and stroke.
The Global Drug Eluting Stent market has been registering a significant growth
in the recent past. This market is witnessing a consolidation of major players
through strategic alliances. Moreover, the Drug Eluting Stent providers are
looking forward to expand their product portfolio to provide a full range of
interventional therapies to the physicians and patients.
The growth in
the demand for the Drug Eluting Stent is due to its increasing acceptance as a
viable treatment. Moreover, the growth is fueled by the robust economic growth
and a greater adoption of social security schemes in the Asian regions. There
are a large number of patients opting for these treatments so as to enhance
their quality of life. Further, developed countries provide easy reimbursement
options for higher-priced Drug Eluting Stent, which makes them affordable for
patients. Moreover reimbursements by national medical savings schemes play a
crucial role in the demand for the Drug Eluting Stents.
The report by
TechNavio Insights forecasts the drug eluting stents market size of the over
the period 2008-2012. Further, it discusses the segmentation of the drug
eluting stents market into various geographic regions. It also identifies the
key market trends, drivers and challenges and profiles some of the key vendors
of this market.
Table of Contents
1. Introduction
2. Global Drug Eluting Stent Market Size & Forecast
3.
Geographic Segmentation
3.1 Drug Eluting Stent Market in Americas
3.2
Drug Eluting Stent Market in EMEA
3.3 Drug Eluting Stent Market in
APAC
4. Market Trends of Global Drug Eluting Stent
5. Sales Drivers of
Global Drug Eluting Stent
6. Market Challenges for Global Drug Eluting
Stent
7. Market Vendors of Drug Eluting Stent
7.1 Abbott
Laboratories
7.2 Biosensors International Group Limited
7.3 Boston
Scientific
7.4 Johnson & Johnson
7.5 Medtronic, Inc.
Other Drug
Eluting Stent Providers
Other Reports in this Series
List of Exhibits
Exhibit 2.1: Global Drug Eluting Stent Market Size and Forecast 2008-2012
(In $ million)
Exhibit 3.1: Drug Eluting Stent Market Segmentation by
Geography -2008
Exhibit 3.2: Americas Drug Eluting Stent Market Size
2008-2012 (in $ millions)
Exhibit 3.3: EMEA Drug Eluting Stent Market Size
2008-2012 (in $ millions)
Exhibit 3.4: APAC Drug Eluting Stent Market Size
2008-2012 (in $ millions)
|
